Austar Lifesciences Limited (6118.HK)

HKD 0.79

(0.0%)

Total Debt Summary of Austar Lifesciences Limited

  • Austar Lifesciences Limited's latest annual total debt in 2023 was 496.19 Million CNY , up 47.44% from previous year.
  • Austar Lifesciences Limited's latest quarterly total debt in 2024 Q2 was 386.27 Million CNY , down -8.63% from previous quarter.
  • Austar Lifesciences Limited reported annual total debt of 336.54 Million CNY in 2022, up 116.81% from previous year.
  • Austar Lifesciences Limited reported annual total debt of 155.22 Million CNY in 2021, up 103.0% from previous year.
  • Austar Lifesciences Limited reported quarterly total debt of 496.19 Million CNY for 2023 Q4, up 16.15% from previous quarter.
  • Austar Lifesciences Limited reported quarterly total debt of 496.19 Million CNY for 2023 FY, up 47.44% from previous quarter.

Annual Total Debt Chart of Austar Lifesciences Limited (2023 - 2013)

Historical Annual Total Debt of Austar Lifesciences Limited (2023 - 2013)

Year Total Debt Total Debt Growth
2023 496.19 Million CNY 47.44%
2022 336.54 Million CNY 116.81%
2021 155.22 Million CNY 103.0%
2020 76.46 Million CNY 30.83%
2019 58.44 Million CNY 125.77%
2018 25.88 Million CNY -45.16%
2017 47.2 Million CNY 136.04%
2016 20 Million CNY -42.86%
2015 35 Million CNY 0.0%
2014 35 Million CNY 75.0%
2013 20 Million CNY 0.0%

Peer Total Debt Comparison of Austar Lifesciences Limited

Name Total Debt Total Debt Difference
Vincent Medical Holdings Limited 37.38 Million HKD -1227.268%